President: Anthony C. Ruocco, PhD

Dr. Ruocco is Professor, Graduate Chair and Director of Clinical Training in the Department of Psychological Clinical Science at the University of Toronto. He is a licensed psychologist registered with the College of Psychologists of Ontario. Dr. Ruocco has received numerous grants and awards for his research on the neurobiology of borderline personality disorder, including from the Canadian Institutes of Health Research, Brain & Behavior Research Foundation, and Province of Ontario. Dr. Ruocco received the NASSPD Mid-Career Investigator Award in 2019. Dr. Ruocco’s research focuses primarily on cognition and psychopathology, including symptoms and maladaptive traits, and extends to family studies and investigations that incorporate measures of brain structure and function.

Vice-President: Sarah Fineberg, MD

Secretary: Katherine Dixon-Gordon, PhD

Dr. Dixon-Gordon is an Associate Professor and Director of Clinical Training in the Department of Psychological and Brain Science at the University of Massachusetts. She is a licensed psychologist and certified in dialectical behavior therapy. Dr. Dixon-Gordon has received numerous grants  for her research on borderline personality disorder, suicide and self-injurious behaviors, and dialectical behavior therapy including from the National Institutes of Health and Canadian Institutes of Health Research. Dr. Dixon-Gordon's research focuses on multimethod investigations of the role of emotions in borderline personality disorder and suicidal behaviors and their treatment. 

Treasurer: Stephanie Stepp, PhD

Dr. Stepp is an Associate Professor of Psychiatry and Psychology at the University of Pittsburgh School of Medicine. She is a clinical psychologist with expertise in Dialectical Behavior Therapy (DBT) and provides treatment to suicidal adolescents with borderline personality disorder as well as their families. Dr. Stepp’s program of research focuses on identifying mechanisms underlying the development of borderline personality disorder and suicidal behavior and those mechanisms facilitating response to treatment.